NCT01157312

Brief Summary

The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(PCOS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 7, 2010

Completed
Last Updated

July 19, 2010

Status Verified

July 1, 2010

Enrollment Period

1.7 years

First QC Date

July 6, 2010

Last Update Submit

July 16, 2010

Conditions

Keywords

Polycystic ovary syndromeclomiphene citrateminimal stimulationinfertility treatment

Outcome Measures

Primary Outcomes (1)

  • clinical pregnancy rate per cycle

Secondary Outcomes (1)

  • endometrial thickness at the time of hCG administration

Study Arms (2)

minimal stimulation protocol

EXPERIMENTAL

5 days of CC (100mg/day) from day 3 followed by 150 IU of highly purified uFSH on cycle day 9 for three treatment cycles

Drug: clomiphene citrate +highly purified uFSH

clomiphene citrate(CC)

ACTIVE COMPARATOR

5 days of CC (100mg/day) from cycle day 3 for three treatment cycles.

Drug: clomiphene citrate

Interventions

minimal stimulation protocol
clomiphene citrate(CC)

Eligibility Criteria

Age20 Years - 39 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • PCOS
  • No other infertility factors
  • No previous use of ovarian stimulation drugs

You may not qualify if:

  • Congenital adrenal hyperplasia
  • Cushing syndrome
  • Androgen secreting tumors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Hospitals,OB/GYN department

Al Mansurah, Dakahlia Governorate, Egypt

Location

Related Publications (4)

  • Lu PY, Chen AL, Atkinson EJ, Lee SH, Erickson LD, Ory SJ. Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility. Fertil Steril. 1996 Mar;65(3):583-7. doi: 10.1016/s0015-0282(16)58158-8.

    PMID: 8774291BACKGROUND
  • Houmard BS, Juang MP, Soules MR, Fujimoto VY. Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment. Fertil Steril. 2002 Feb;77(2):384-6. doi: 10.1016/s0015-0282(01)02990-9.

    PMID: 11821101BACKGROUND
  • Dhaliwal LK, Sialy RK, Gopalan S, Majumdar S. Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility. J Obstet Gynaecol Res. 2002 Dec;28(6):295-9. doi: 10.1046/j.1341-8076.2002.00058.x.

    PMID: 12512925BACKGROUND
  • Abu Hashim H, Bazeed M, Abd Elaal I. Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial. Gynecol Endocrinol. 2012 Feb;28(2):87-90. doi: 10.3109/09513590.2011.589924. Epub 2011 Jul 20.

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Clomiphene

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

StilbenesBenzylidene CompoundsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Hatem Abu Hashim, MD MRCOG

    Mansoura University Hospital

    PRINCIPAL INVESTIGATOR
  • Mohamed F Bazeed, MD

    Mansoura University Hospital

    STUDY DIRECTOR
  • Ibrahim Abd Elaal, MD

    Mansoura University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 6, 2010

First Posted

July 7, 2010

Study Start

August 1, 2008

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

July 19, 2010

Record last verified: 2010-07

Locations